[Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 17, n. 2S, p. 13–36, 2016. DOI: 10.7175/fe.v17i2S.1230. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1230. Acesso em: 29 oct. 2025.